Latest in Cell & Gene Therapy

Northway Biotech opens €61m cell therapy CDMO in Lithuania

The new 3500 sq m Vilnius facility will provide up to 20 independent cGMP manufacturing lines for cell therapies and personalised medicines

Find out more
Northway Biotech opens €61m cell therapy CDMO in Lithuania

Systech launches AI-powered traceability platform for pharma supply chains

Systech launches AI-powered traceability platform for pharma supply chains

Systech International has launched TraceIQ, a new traceability platform combining pharmaceutical compliance capabilities with AI-assisted analytics to help manufacturers...
See more
Waterfall Scientific heads $54.5m ARPA-H consortium to build continuous-flow mRNA manufacturing platform

Waterfall Scientific heads $54.5m ARPA-H consortium to build continuous-flow mRNA manufacturing platform

The ESCALATOR project integrates enzymatic DNA synthesis, LNP formulation, microfluidics and automated analytics into an end-to-end system — aiming to reduce production lead time from weeks to days for personalised oncology and pandemic response
NewBiologix and Synastra Biotechnology partner for stable rAAV manufacturing in DMD gene therapy

NewBiologix and Synastra Biotechnology partner for stable rAAV manufacturing in DMD gene therapy

The pair will use NewBiologix's Xcell platform to establish a stable producer cell line to scale manufacturing for Synastra’s investigational DMD gene therapy programme
Novartis and BMS slam breaks on gene therapy trials after adverse events

Novartis and BMS slam breaks on gene therapy trials after adverse events

Three patients have reportedly died in Novartis' experimental trials of its CAR-T therapy for autoimmune conditions, causing the pharma giant to halt eight of its clinical trials, with BMS pausing enrollment for its own CAR-T treatment for similar issues
Beyond specialisation: why integrated CDMO capabilities matter for next-gen therapies

Beyond specialisation: why integrated CDMO capabilities matter for next-gen therapies

Complex therapies require CDMO partners with co‑ordinated scientific, analytical, manufacturing and operational expertise to reduce development risk
Andelyn Biosciences partners with Queen's University Belfast for GM2 Gangliosides candidate

Andelyn Biosciences partners with Queen's University Belfast for GM2 Gangliosides candidate

The CGT company will use its Curator Platform to advance AAV9-GM2 towards patient dosing through a multiphase programme, supporting the University in bringing the potentially "life-changing therapy" to patients
DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction

DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction

The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows
Touchlight’s dbDNA used in first UK personalised lung cancer vaccine

Touchlight’s dbDNA used in first UK personalised lung cancer vaccine

The first UK patient has received a personalised DNA cancer vaccine manufactured using Touchlight’s cell-free dbDNA technology, in a Phase I trial investigating a potential new treatment for advanced non-small cell lung cancer
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Latest posts in Cell & Gene Therapy

Novogene Europe boosts single-cell sequencing capacity at Cambridge Omics Centre

Novogene Europe boosts single-cell sequencing capacity at Cambridge Omics Centre

Following hot on the heels of the launch of its Untargeted Metabolomics Service, Novogene said the expansion marks the next step in a broader phase of capability expansion at the site
UK Intracellular Drug Delivery Centre opens doors for broader industry access

UK Intracellular Drug Delivery Centre opens doors for broader industry access

Following on from a capability development phase, the CPI-led centre is now open to the broader industry, creating a new national route for companies developing next-generation RNA therapies to generate data for clinical and commercial application
eXmoor Pharma and Evox Therapeutics complete technology transfer for Huntington's gene editing programme

eXmoor Pharma and Evox Therapeutics complete technology transfer for Huntington's gene editing programme

The successful establishment of Evox's proprietary manufacturing process and analytical methods at eXmoor's Bristol facility lays the technical foundation for GMP transfer and future clinical manufacture of the MSH3-targeted therapy
UNC Charlotte and BioCytics target cancer ‘dark genome’ with multi-omics platform

UNC Charlotte and BioCytics target cancer ‘dark genome’ with multi-omics platform

Two-year research collaboration will combine long-read sequencing, immune profiling and computational analysis to identify viral and genomic drivers of cancer and support personalised treatment decisions
Grünenthal joins genetic medicine cluster CNATM to advance RNA therapeutics

Grünenthal joins genetic medicine cluster CNATM to advance RNA therapeutics

The pain specialist has joined the Cluster for Nucleic Acid Therapeutics Munich to strengthen its oligonucleotide drug discovery capabilities and accelerate the development of genetic medicines for neurological diseases
Cellares and Sonoma Biotherapeutics automate Treg cell therapy manufacturing on Cell Shuttle platform

Cellares and Sonoma Biotherapeutics automate Treg cell therapy manufacturing on Cell Shuttle platform

SBT-77-7101 becomes the first regulatory T cell programme to onboard to the Cell Shuttle, bringing automated cGMP manufacturing and QC infrastructure to a CAR-Treg therapy in Phase I trials for poly-refractory rheumatoid arthritis
Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents

Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents

The duo will work to develop improved reagents for gene regulation research, with Abcam already integrating data from EpiCypher's CUTANA ChIC/CUT&RUN platform into its portfolio
Vitalant adds NGS testing to Pittsburgh lab as part of national cell and gene therapy strategy

Vitalant adds NGS testing to Pittsburgh lab as part of national cell and gene therapy strategy

The expansion connects Phoenix, San Francisco and Pittsburgh laboratories into a hub-and-spoke model, strengthening analytical support for CGT development, transfusion medicine and inherited bleeding disorder diagnostics
OrganaBio expands rapid PBMC processing to San Diego at Excellos Labs

OrganaBio expands rapid PBMC processing to San Diego at Excellos Labs

OrganaBio launches time-sensitive PBMC isolation in San Diego, extending rapid clinical sample processing to one of the largest cell and gene therapy hubs in the country
Syntax Bio and Applied StemCell partner to advance programmable iPSC therapy development

Syntax Bio and Applied StemCell partner to advance programmable iPSC therapy development

The collaboration combines ASC's hypoimmune iPSC lines with Syntax Bio's Cellgorithm platform, aiming to accelerate scalable allogeneic cell therapy development by addressing immune recognition and manufacturing variability
Lonza and InduPro reveal licensing agreement to advance next-generation ADC therapeutics

Lonza and InduPro reveal licensing agreement to advance next-generation ADC therapeutics

The agreement enables InduPro to leverage Lonza platforms to develop targeted oncology therapies

Sponsor content

Bio-Rad launches Vericheck ddPCR Kits

Bio-Rad launches Vericheck ddPCR Kits

Compatible with QX700 Platform for biopharma quality control and cell and gene therapy workflows
Andelyn Biosciences strengthens CDMO credentials with full ICMC certification

Andelyn Biosciences strengthens CDMO credentials with full ICMC certification

The certification received by Andelyn underscores their long-standing commitment to quality, operational readiness, and client service as the company supports innovators...
Optimising cryovial filling and cryopreservation for reliable cell functionality

Optimising cryovial filling and cryopreservation for reliable cell functionality

An integrated equipment workflow for consistent post-thaw viability and function recovery
PromoCell launches GMP cell culture media services for cell therapy

PromoCell launches GMP cell culture media services for cell therapy

New offering to debut at 32nd ESGCT Congress, October 7–10 in Seville, Spain
The basics of cell culture

The basics of cell culture

Key steps in manufacturing cell therapies
A smarter alternative to pipette-filling cryovials

A smarter alternative to pipette-filling cryovials

By switching to an automated cryovial filling solution, such as award-winning cryoFIL, manufacturers remove one of the most error-prone, resource-heavy steps from their...
The challenges and trends in gene therapy

The challenges and trends in gene therapy

Three perspectives on the challenges and trends in gene therapy
Andelyn Biosciences adds Stanton Lab CNS Capsids to AAV Curator Platform

Andelyn Biosciences adds Stanton Lab CNS Capsids to AAV Curator Platform

Andelyn Biosciences expands AAV Curator® Platform offering to include Stanton Lab CNS Capsids through a license agreement from the Broad Institute of MIT and Harvard
Ensuring cGMP compliance in cell and gene therapy manufacturing

Ensuring cGMP compliance in cell and gene therapy manufacturing

By adhering to GMP principles, manufacturers can mitigate risks, streamline processes, and ensure that their products meet the highest standards of safety and efficacy
Andelyn Biosciences produces viral vector for Nationwide Children’s Hospital using AAV Curator Platform

Andelyn Biosciences produces viral vector for Nationwide Children’s Hospital using AAV Curator Platform

Andelyn Biosciences AAV Curator® Platform used to manufacture clinical grade viral vector for FDA-Authorised first-in-world Universal Donor CRISPR/AAV Transduced CAR-NK...
Andelyn applies AAV Curator to treat ultra-rare NEDAMSS patient

Andelyn applies AAV Curator to treat ultra-rare NEDAMSS patient

Andelyn Biosciences applies the AAV Curator platform to deliver novel gene therapy for an ultra-rare NEDAMSS disease patient 14-months after diagnosis
AnalytiChem debuts branded Redipor culture media

AnalytiChem debuts branded Redipor culture media

The branded culture media line combines the expertise of BioTrading, Redipor by Cherwell and NEL to provide customers with tailored batch sizes, formulations and packaging...